Transplant Biomedicals Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Transplant Biomedicals General Information

Description

Developer of medical devices intended to improve organ, tissue and cellular preservation. The company's devices leverage proprietary technology to reduce the risk of delayed graft function, improve graft survival and use part of marginal organs that are currently discarded, enabling medical practitioners to transport organs and tissues from donor hospitals to the transport center in a safe and effective way.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Marie Curie, 8-14
  • Barcelona Advanced Industry Park
  • 08042 Barcelona
  • Spain
Primary Industry
Other Devices and Supplies
Other Industries
Therapeutic Devices
Corporate Office
  • Marie Curie, 8-14
  • Barcelona Advanced Industry Park
  • 08042 Barcelona
  • Spain

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Transplant Biomedicals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 28-Jan-2020 Completed Out of Business
4. Early Stage VC Completed Generating Revenue
3. Early Stage VC (Series A) 03-Jan-2017 Completed Generating Revenue
2. Seed Round 11-Nov-2015 $1.66M $1.59M Completed Generating Revenue
1. Angel (individual) $7.62K $7.62K Completed Startup
To view Transplant Biomedicals’s complete valuation and funding history, request access »

Transplant Biomedicals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 17,436 $1.051223 $39.23 $39.23 1x $39.23 24.96%
To view Transplant Biomedicals’s complete cap table history, request access »

Transplant Biomedicals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medical devices intended to improve organ, tissue and cellular preservation. The company's devices leverage
Other Devices and Supplies
Barcelona, Spain

Oxford, United Kingdom
 

Danvers, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Transplant Biomedicals Competitors (8)

One of Transplant Biomedicals’s 8 competitors is OrganOx, a Formerly PE-Backed company based in Oxford, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
OrganOx Formerly PE-Backed Oxford, United Kingdom
Abiomed Corporate Backed or Acquired Danvers, MA
TransMedics Group Formerly VC-backed Andover, MA
Lifeline Scientific Formerly VC-backed Itasca, IL
SynCardia Systems Formerly PE-Backed Tucson, AZ
You’re viewing 5 of 8 competitors. Get the full list »

Transplant Biomedicals FAQs

  • When was Transplant Biomedicals founded?

    Transplant Biomedicals was founded in 2014.

  • Where is Transplant Biomedicals headquartered?

    Transplant Biomedicals is headquartered in Barcelona, Spain.

  • What industry is Transplant Biomedicals in?

    Transplant Biomedicals’s primary industry is Other Devices and Supplies.

  • Is Transplant Biomedicals a private or public company?

    Transplant Biomedicals is a Private company.

  • What is Transplant Biomedicals’s current revenue?

    The current revenue for Transplant Biomedicals is .

  • How much funding has Transplant Biomedicals raised over time?

    Transplant Biomedicals has raised $4.22M.

  • Who are Transplant Biomedicals’s competitors?

    OrganOx, Abiomed, TransMedics Group, Lifeline Scientific, and SynCardia Systems are some of the 8 competitors of Transplant Biomedicals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process